Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-25-003337
Filing Date
2025-02-07
Accepted
2025-02-07 16:00:13
Documents
1
Period of Report
2024-02-15

Document Format Files

Seq Description Document Type Size
1 form4a-02072025_040201.html 4/A  
1 form4a-02072025_040201.xml 4/A 13348
  Complete submission text file 0001415889-25-003337.txt   14733
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Issuer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address
Thakkar Roopal (Reporting) CIK: 0002004979 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35565 | Film No.: 25601545